drugs

Production issues have led to a limited supply of the cancer drug ifosfamide, which is expected to last for several months. While international imports have provided some relief, doctors are now following new clinical guidelines to manage dosages and treatment schedules. These temporary measures aim to ensure patients continue to receive effective care despite the manufacturing constraints.